| 1 |
Dabaj I , Ducatez F , Marret S , Bekri S , Tebani A . Neuromuscular disorders in the omics era. Clin Chim Acta, 2024, 553: 117691.
|
| 2 |
Xiong H . Progress and challenges in diagnosis and treatment of neuromuscular disease in children. Zhongguo Xiao Er Ji Jiu Yi Xue, 2023, 30: 401- 404.
|
|
熊晖. 儿童神经肌肉病诊治进展与挑战. 中国小儿急救医学, 2023, 30: 401- 404.
|
| 3 |
Rathore G , Kang PB . Pediatric neuromuscular diseases. Pediatr Neurol, 2023, 149: 1- 14.
|
| 4 |
Duarte DM , da Silva Lima MB , Sepodes B . Trends from two decades of orphan designations in paediatric rare neuromuscular diseases. J Neurol Sci, 2024, 460: 122989.
|
| 5 |
Schlaffke L , Rehmann R , Güttsches AK , Vorgerd M , Meyer-Frießem CH , Dinse HR , Enax-Krumova E , Froeling M , Forsting J . Evaluation of neuromuscular diseases and complaints by quantitative muscle MRI. J Clin Med, 2024, 13: 1958.
|
| 6 |
Yang AQ , Li WZ , Huang Z . Advance in clinical functional assessment of neuromuscular disease (review). Zhongguo Kang Fu Li Lun Yu Shi Jian, 2020, 26: 923- 929.
|
|
杨安琪, 李文竹, 黄真. 神经肌肉病患者功能评定的临床应用进展. 中国康复理论与实践, 2020, 26: 923- 929.
|
| 7 |
Ribault S , Rippert P , Jain M , Le Goff L , Genod DV , Barriere A , Berruyer A , Garde C , Tinat M , Pons C , Vuillerot C . Psychometric characteristics of the motor function measure in neuromuscular diseases: a systematic review. J Neuromuscul Dis, 2023, 10: 301- 314.
|
| 8 |
Sigurðardóttir B , Gribsholt SB , Bjerregaard LG , Bruun JM . Review of impacts of using body mass index as a screening tool in school children: a scoping review. Clin Obes, 2024, 14: e12639.
|
| 9 |
Scott OM , Hyde SA , Goddard C , Dubowitz V . Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve, 1982, 5: 291- 301.
|
| 10 |
Bérard C , Payan C , Hodgkinson I , Fermanian J , MFM Collaborative Study Group . A motor function measure for neuromuscular diseases: construction and validation study. Neuromuscul Disord, 2005, 15: 463- 470.
|
| 11 |
Huang M , Cao J , Sun J , Li W , Qin L , Li H , Zhai C , Huang W , Gui T , Zhang K , Wang J , Vuillerot C , Wang Y , Dai M . Cross-cultural adaptation and multi-centric validation of the Motor Function Measure Chinese version (MFM-32-CN) for patients with neuromuscular diseases. Dev Neurorehabil, 2020, 23: 210- 217.
|
| 12 |
de Groot IJ . Editorial: motor function measure in Duchenne muscular dystrophy. Eur J Paediatr Neurol, 2022, 36: A5.
|
| 13 |
Brooke MH , Griggs RC , Mendell JR , Fenichel GM , Shumate JB , Pellegrino RJ . Clinical trial in Duchenne dystrophy. Ⅰ: the design of the protocol. Muscle Nerve, 1981, 4: 186- 197.
|
| 14 |
Vignos PJ Jr , Spencer GE Jr , Archibald KC . Management of progressive muscular dystrophy in childhood. JAMA, 1963, 184: 89- 96.
|
| 15 |
Dowling JJ , D Gonorazky H , Cohn RD , Campbell C . Treating pediatric neuromuscular disorders: the future is now. Am J Med Genet A, 2018, 176: 804- 841.
|
| 16 |
Ruiz-Cortes X , Ortiz-Corredor F , Mendoza-Pulido C . Reliability of home-based, motor function measure in hereditary neuromuscular diseases. J Int Med Res, 2017, 45: 261- 271.
|
| 17 |
Conde RM , de Almeida Pereira Pena L , do Nascimento Elias AH , Guerreiro CT , Pereira DA , da Rosa Sobreira CF , Marques WJr , Barreira AA . Inter-rater reliability of the Rasch-modified medical research council scoring criteria for manual muscle testing in neuromuscular diseases. J Peripher Nerv Syst, 2023, 28: 119- 124.
|
| 18 |
Bouman K , Groothuis JT , Doorduin J , van Alfen N , Udink Ten Cate FEA , van den Heuvel FMA , Nijveldt R , Kamsteeg EJ , Dittrich ATM , Draaisma JMT , Janssen MCH , van Engelen BGM , Erasmus CE , Voermans NC . LAMA2-related muscular dystrophy across the life span: a cross-sectional study. Neurol Genet, 2023, 9: e200089.
|
| 19 |
Hafner P , Schmidt S , Schädelin S , Rippert P , Hamroun D , Fabien S , Henzi B , Putananickal N , Rubino-Nacht D , Vuillerot C , Fischer D , MFM Registry Study Group . Implementation of Motor Function Measure score percentile curves: predicting motor function loss in Duchenne muscular dystrophy. Eur J Paediatr Neurol, 2022, 36: 78- 83.
|
| 20 |
Decostre V , De Antonio M , Servais L , Hogrel JY . Relationship between hand strength and function in Duchenne muscular dystrophy and spinal muscular atrophy: implications for clinical trials. J Neuromuscul Dis, 2024, 11: 777- 790.
|
| 21 |
Andrade KKS , Soares LA , Macedo CC , Bispo NR , Sousa Junior RR , Oliveira VC , Leite HR , Gaiad TP . Quality of instruments assessing activity and participation of people with muscular dystrophy: a systematic review of participant-reported outcome measures. Dev Med Child Neurol, 2022, 64: 1453- 1461.
|
| 22 |
Oskoui M , Day JW , Deconinck N , Mazzone ES , Nascimento A , Saito K , Vuillerot C , Baranello G , Goemans N , Kirschner J , Kostera-Pruszczyk A , Servais L , Papp G , Gorni K , Kletzl H , Martin C , McIver T , Scalco RS , Staunton H , Yeung WY , Fontoura P , Mercuri E , SUNFISH Working Group . Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA). J Neurol, 2023, 270: 2531- 2546.
|
| 23 |
Mercuri E , Deconinck N , Mazzone ES , Nascimento A , Oskoui M , Saito K , Vuillerot C , Baranello G , Boespflug-Tanguy O , Goemans N , Kirschner J , Kostera-Pruszczyk A , Servais L , Gerber M , Gorni K , Khwaja O , Kletzl H , Scalco RS , Staunton H , Yeung WY , Martin C , Fontoura P , Day JW , SUNFISH Study Group . Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial. Lancet Neurol, 2022, 21: 42- 52.
|
| 24 |
Cesar S , Campuzano O , Cruzalegui J , Fiol V , Moll I , Martínez-Barrios E , Zschaeck I , Natera-de Benito D , Ortez C , Carrera L , Expósito J , Berrueco R , Bautista-Rodriguez C , Dabaj I , Gómez García-de-la-Banda M , Quijano-Roy S , Brugada J , Nascimento A , Sarquella-Brugada G . Characterization of cardiac involvement in children with LMNA-related muscular dystrophy. Front Cell Dev Biol, 2023, 11: 1142937.
|
| 25 |
Kramarenko D , Walsh R . Emery-Dreifuss muscular dystrophy: a closer look at cardiac complications. Eur Heart J, 2023, 44: 5074- 5076.
|
| 26 |
Adaikina A , Derraik JGB , Power LC , Grady GO , Munns CF , Hofman PL , Gusso S . Feasibility, safety, and efficacy of 12-week side-to-side vibration therapy in children and adolescents with congenital myopathy in New Zealand. Neuromuscul Disord, 2022, 32: 820- 828.
|
| 27 |
Le Goff L , Meilleur KG , Norato G , Rippert P , Jain M , Fink M , Foley AR , Waite M , Donkervoort S , Bönnemann CG , Vuillerot C . Responsiveness and minimal clinically important difference of the motor function measure in collagen Ⅵ-related dystrophies and laminin alpha2-related muscular dystrophy. Arch Phys Med Rehabil, 2021, 102: 604- 610.
|
| 28 |
Stinissen L , Bouma S , Böhm J , van Tienen J , Fischer H , Hughes Z , Lennox A , Ward E , Wood M , Foley AR , Oortwijn W , Jungbluth H , Voermans NC . The experience of clinical study and trial participation in rare diseases: a scoping review of centronuclear myopathy and other neuromuscular disorders. Neuromuscul Disord, 2024, 38: 1- 7.
|
| 29 |
Duong T , Braid J , Staunton H , Barriere A , Petridis F , Reithinger J , Cruz R , Jarecki J , De Lemus M , Gusset N , Broekgaarden R , Randhawa S , Flynn J , Arbuckle R , Reif S , Yang L , De Martini A , Vuillerot C . Understanding the relationship between the 32-item motor function measure and daily activities from an individual with spinal muscular atrophy and their caregivers'perspective: a two-part study. BMC Neurol, 2021, 21: 143.
|
| 30 |
Li WZ , Wang CH , Huang Z , Wei CJ , Xiong H , Xu BY , Li CD , Que CL . Perioperative rehabilitation management for a child with spinal muscular atrophy: one case report. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2023, 23: 838- 843.
doi: 10.3969/j.issn.1672-6731.2023.09.011
|
|
李文竹, 王晨昊, 黄真, 魏翠洁, 熊晖, 徐贝宇, 李淳德, 阙呈立. 儿童脊髓性肌萎缩症围手术期康复治疗一例. 中国现代神经疾病杂志, 2023, 23: 838- 843.
doi: 10.3969/j.issn.1672-6731.2023.09.011
|